LONDON, May 30 (Reuters) - The Wellcome Trust medical
charity is to profit from U.S. approval of a new diagnostic
cancer test, the first commercial product funded by the
organisation since the sale of its pharmaceuticals business to
Glaxo in 1995.
Read more
No comments:
Post a Comment